Sr.No.,Schedule Date,Locality,Age,Gender,Modality,Type of Procedure(s) Requested,Type of Test(s) Requested,Test Result(s),Provisional Diagnosis,Principal Diagnosis,Additional Diagnosis,Pregnant Patient,NHIA Patient,Medicine Prescribed,Medicine Dispensed,Occupation,Ward/Room,Date of Admission,Date of Discharge,Outcome of Discharge,Surgical Procedure,Cost of Treatment (GHS ),Admission Type,E-tracking Number
6,30-11-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,30-11-2024,30-11-2024,,,0,OPD,
44,30-11-2024,ANYAA,56 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> OLD,,No,Insured,,,,,30-11-2024,30-11-2024,,,40,OPD,
50,30-11-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,30-11-2024,30-11-2024,,,0,OPD,
78,30-11-2024,SANTA MARIA A LANG,73 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> RECURRING,I10.00 [Essential (primary) hypertension]  ==> RECURRING,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,30-11-2024,30-11-2024,,,0,OPD,
473,29-11-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,29-11-2024,29-11-2024,,,10,OPD,
930,28-11-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,28-11-2024,28-11-2024,,,0,OPD,
932,28-11-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,28-11-2024,28-11-2024,,,30,OPD,
1004,28-11-2024,new bortianor,70 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> RECURRING",No,Insured,"LIVERESS FORTE[ LIVERESS FORTE |  | Capsule | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], SITAGLIPTIN 100MG[ JANUVIA | 100MG | Tablet | OD |  For 30 Days  ]","LIVERESS FORTE[ LIVERESS FORTE |  | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], SITAGLIPTIN 100MG[ JANUVIA | 100MG | Tablet ]",,,28-11-2024,28-11-2024,,,10,OPD,
1006,28-11-2024,BORTIANOR-APLAKU,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Mane |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,28-11-2024,28-11-2024,,,10,OPD,
1011,28-11-2024,ODORKOR-TECNO,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,28-11-2024,28-11-2024,,,0,OPD,25713/19
1024,28-11-2024,AMANFROM-KALABULEY,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,28-11-2024,28-11-2024,,,10,OPD,
1027,28-11-2024,"WEIJA , CHOICE ",56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Non-Insured,,,,,28-11-2024,28-11-2024,,,60,OPD,
1030,28-11-2024,gbawe top base,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,28-11-2024,28-11-2024,,,0,OPD,
1041,28-11-2024,TETEGU,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]",,,,28-11-2024,28-11-2024,,,0,OPD,
1042,28-11-2024,AGAPE ,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,TRADER,,28-11-2024,28-11-2024,,,10,OPD,
1199,28-11-2024,ANYAA,56 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> OLD,,No,Insured,,,,,28-11-2024,28-11-2024,,,30,OPD,
1281,28-11-2024,new applaku,60 Year(s),Female,SPECIALIST CLINIC ,CONSULTATION REVIEW (ADULT),,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, I69.4 [Sequelae of stroke, not specified as haemorrhage or infarction]  ==> OLD, F06.31 [Mood disorder due to known physiological condition with depressive features]  ==> NEW, D50.9 [Iron deficiency anaemia, unspecified]  ==> NEW",No,Non-Insured,"FLUOXETINE [ FLUOXETINE  | 20MG | Tablet | OD |  For 60 Days  ], IRON(III)POLYMALTOSE COMPLEX SUSPENSION[ IRON (111)POLYMALTOSE COMPLEX  | 200ML | Syrup | OD |  For 30 Days  ]","FLUOXETINE [ FLUOXETINE  | 20MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX SUSPENSION[ IRON (111)POLYMALTOSE COMPLEX  | 200ML | Syrup ]",,,28-11-2024,28-11-2024,,,170,OPD,
1285,28-11-2024,lower mccarthy,69 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,,,28-11-2024,28-11-2024,,,50,OPD,
1329,28-11-2024,ASOFA,42 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,,No,Insured,"GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 0 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], SITAGLIPTIN 100MG[ JANUVIA | 100MG | Tablet | OD |  For 30 Days  ]","GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], SITAGLIPTIN 100MG[ JANUVIA | 100MG | Tablet ]",,,28-11-2024,28-11-2024,,,20,OPD,
1448,28-11-2024,"KASOA , KAKRABA - DOWN ",37 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 0 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TEACHER,,28-11-2024,28-11-2024,,,0,OPD,
1509,28-11-2024,TETEGU ,68 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,TRADER,,28-11-2024,28-11-2024,,,60,OPD,
1738,27-11-2024,"AWOSHIE
MANGOASE",50 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,,,TRADER,,27-11-2024,27-11-2024,,,20,OPD,
1750,27-11-2024,ABLEKUMAH ODUMAN,64 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,A09.9 [Gastroenteritis and colitis of unspecified origin]  ==> NEW,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | Stat |  For 1 Days  ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | OD |  For 1 Days  ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], ORAL REHYDRATION SALTS [  O.R.S. | 25G | Powder | BDS |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion | Stat |  For 1 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 7 Days  ], METRONDAZOLE TABLET 200MG[ METRONIDAZOLE 200MG | 200MG | Tablet | BDS |  For 7 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BDS |  For 7 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 1 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Stat |  For 1 Days  ], ACETYLSALICY","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], ORAL REHYDRATION SALTS [  O.R.S. | 25G | Powder ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], METRONDAZOLE TABLET 200MG[ METRONIDAZOLE 200MG | 200MG | Tablet ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",Unemployed,,27-11-2024,27-11-2024,,,125,OPD,
1760,27-11-2024,KANESHIE,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,27-11-2024,27-11-2024,,,0,OPD,
1804,27-11-2024,MENDS KRROM,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,27-11-2024,27-11-2024,,,0,OPD,
1887,27-11-2024,gbawe top base,66 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]",,,,27-11-2024,27-11-2024,,,0,OPD,
1957,27-11-2024,awoshie,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"M25.9 [Joint disorder, unspecified]  ==> OLD, I10. [Essential (primary) hypertension]  ==> OLD",No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,27-11-2024,27-11-2024,,,90,OPD,
2563,27-11-2024,KASOA AMANFROM,58 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I15.8 [Other secondary hypertension]  ==> OLD,No,Non-Insured,,,TRADER,,27-11-2024,27-11-2024,,,170,OPD,
2571,27-11-2024,AUNTIE AKU,53 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"G40.6 [Grand mal seizures, unspecified (with or without petit mal)]  ==> NEW, I15.8 [Other secondary hypertension]  ==> NEW",No,Insured,"PHENYTOIN INJECTION 50MG/ML IN 5ML[ PHENYTOIN SODIUM | 50MG/ML | Injection | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion | Stat |  For 1 Days  ], DIAZEPAM INJECTION 10MG[ DIAZEPAM | 5MG/ML IN2ML | Injection | Stat |  For 1 Days  ], MIDAZOLAM INJECTION 5MG/5ML[ MIDAZOLAM | 5MG/ML | Injection | Stat |  For 1 Days  ]","PHENYTOIN INJECTION 50MG/ML IN 5ML[ PHENYTOIN SODIUM | 50MG/ML | Injection ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion ], DIAZEPAM INJECTION 10MG[ DIAZEPAM | 5MG/ML IN2ML | Injection ], MIDAZOLAM INJECTION 5MG/5ML[ MIDAZOLAM | 5MG/ML | Injection ]",driver,,27-11-2024,27-11-2024,,,100,OPD,
2648,26-11-2024,BLOCK FACTORY OLD SOLDIER LINE,63 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | 6x/day |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 0 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,,,26-11-2024,26-11-2024,,,10,OPD,
2656,26-11-2024,ABLEKUMA GALILEA,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,26-11-2024,26-11-2024,,,0,OPD,
2658,26-11-2024,mallam station,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ]",,,,26-11-2024,26-11-2024,,,10,OPD,
2663,26-11-2024,kasoa,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 0 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,26-11-2024,26-11-2024,,,10,OPD,
2678,26-11-2024,"MALLAM
NEW LIFE SCHOOL",74 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,,,26-11-2024,26-11-2024,,,60,OPD,
2700,26-11-2024,KASOA,55 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,TRADER,,26-11-2024,26-11-2024,,,50,OPD,
2758,26-11-2024,WEIJA,79 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,26-11-2024,26-11-2024,,,0,OPD,
2761,26-11-2024,AWOSHIE,76 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",pension,,26-11-2024,26-11-2024,,,15,OPD,
2770,26-11-2024,"NEW GBAWE , TIME SPOT",53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,26-11-2024,26-11-2024,,,10,OPD,
2856,26-11-2024,ABEKLUMA,42 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,"antenatal antenatal, moderate anemia in cyesis",O24.4 [Diabetes mellitus arising in pregnancy]  ==> NEW,"Z34.82 [Encounter for supervision of other normal pregnancy, second trimester]  ==> OLD, B37.3 [Candidiasis of vulva and vagina]  ==> NEW",Yes,Insured,"FERROUS ASCORBATE+FOLIC ACID [ FEMOM | 30MG+55OMCG/5ML | Suspension | BDS |  For 30 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | TDS |  For 30 Days  ], FERROUS SULPHATE[ FERROUS SULPHATE (60MG ELEMENTAL) | 60mg | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet | Nocte |  For 3 Days  ]","FERROUS ASCORBATE+FOLIC ACID [ FEMOM | 30MG+55OMCG/5ML | Suspension ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], FERROUS SULPHATE[ FERROUS SULPHATE (60MG ELEMENTAL) | 60mg | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet ]",hairdresser,,26-11-2024,26-11-2024,,,0,OPD,
2951,26-11-2024,"TUBA , KAKRABA",52 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,TRADER,,26-11-2024,26-11-2024,,,50,OPD,
2977,26-11-2024,"AGONA SWEDRU, MAHONDWE",58 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],FARMER,,26-11-2024,26-11-2024,,,0,OPD,
2988,26-11-2024,KASOA,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ],,,,26-11-2024,26-11-2024,,,10,OPD,
3084,26-11-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,26-11-2024,26-11-2024,,,0,OPD,
3089,26-11-2024,KASOA AKWELEY,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]",,TRADER,,26-11-2024,26-11-2024,,,10,OPD,
3281,26-11-2024,,70 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"K29.1 [Other acute gastritis]  ==> NEW, G62.9 [Polyneuropathy, unspecified]  ==> NEW",No,Insured,"OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 14 Days  ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule | BDS |  For 14 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Tablet | BDS |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]",,,,26-11-2024,26-11-2024,,,0,OPD,
3398,26-11-2024,GBAWE ZERO,43 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | TID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",TRADER,,26-11-2024,26-11-2024,,,70,OPD,
3513,25-11-2024,AMASAMAN T JUNCTION ,53 Year(s),Female,DERMATOLOGY CLINIC,Derma Consultation Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,GLICLAZIDE [ DIAMICRON | 60MG | Tablet | OD |  For 14 Days  ],,TRADER,,25-11-2024,25-11-2024,,,10,OPD,
3514,25-11-2024,WEIJA ITS,55 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,,,25-11-2024,25-11-2024,,,80,OPD,
3555,25-11-2024,weija,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ]","VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,25-11-2024,25-11-2024,,,0,OPD,
3597,25-11-2024,"ANYAA ,NIC ",64 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.311 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-11-2024,25-11-2024,,,0,OPD,
3610,25-11-2024,"TUBA
MOUNTAIN VIEW",40 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-11-2024,25-11-2024,,,0,OPD,
3664,25-11-2024,AGAPE UP TWON,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.42 [Diabetes mellitus due to underlying condition with diabetic polyneuropathy]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ]","BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",Para Professional,,25-11-2024,25-11-2024,,,0,OPD,
3671,25-11-2024,galileye,71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> RECURRING","I10. [Essential (primary) hypertension]  ==> OLD, E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD",No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Once |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Once |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-11-2024,25-11-2024,,,0,OPD,
3679,25-11-2024,awoshie A LANE,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Non-Insured,"PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-11-2024,25-11-2024,,,0,OPD,
3713,25-11-2024,mccarthy,68 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel | PRN |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel ]",,,25-11-2024,25-11-2024,,,0,OPD,
3774,25-11-2024,"gbawe
",71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 60 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,25-11-2024,25-11-2024,,,0,OPD,
3860,25-11-2024,scc behind new vision hotel,58 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-11-2024,25-11-2024,,,0,OPD,
4008,25-11-2024,MALLAM,58 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | QID |  For 3 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 15 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,25-11-2024,25-11-2024,,,135,OPD,
4471,25-11-2024,AWOSHIE BARNYARD,47 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.29 [Type 2 diabetes mellitus with other diabetic kidney complication]  ==> NEW,,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 10 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 5 Days  ]",,TRADER,,25-11-2024,25-11-2024,,,65,OPD,
4531,24-11-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,24-11-2024,24-11-2024,,,120,OPD,
4543,24-11-2024,KANESHIE,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,24-11-2024,24-11-2024,,,0,OPD,
4564,24-11-2024,OLD  -BORTIANOR,49 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,TRADER,,24-11-2024,24-11-2024,,,0,OPD,
4646,24-11-2024,DANSOMAN-BEACH,62 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> RECURRING,,No,Insured,SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ],SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ],,,24-11-2024,24-11-2024,,,155,OPD,
4719,23-11-2024,GBAWE,58 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I11.0 [Hypertensive heart disease with (congestive) heart failure]  ==> NEW,No,Insured,"FERROUS GLUCONATE  SYRUP[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup | BDS |  For 14 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","FERROUS GLUCONATE  SYRUP[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",SPARE PART,,23-11-2024,23-11-2024,,,10,OPD,
4907,23-11-2024,GBAWE,79 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.649 [Diabetes mellitus due to underlying condition with hypoglycemia without coma]  ==> NEW,,No,Insured,,,,,23-11-2024,23-11-2024,,,590,OPD,
4969,22-11-2024,ANYAA,56 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E10.69 [Type 1 diabetes mellitus with other specified complication]  ==> OLD,,No,Insured,,,,,22-11-2024,22-11-2024,,,0,OPD,
4989,22-11-2024,new bortianor,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ]",,,22-11-2024,22-11-2024,,,0,OPD,
4991,22-11-2024,SCC-TOP,79 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], URO 500 CAPSULES[ URO 500 |  | Capsule | TID |  For 14 Days  ]",,Retired,,22-11-2024,22-11-2024,,,10,OPD,
5100,22-11-2024,AWOSHIE ABRANTIE,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.22 [Type 2 diabetes mellitus with diabetic chronic kidney disease]  ==> NEW,,No,Insured,TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | Daily |  For 30 Days  ],,PENSIONEER,,22-11-2024,22-11-2024,,,0,OPD,
5385,22-11-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,22-11-2024,22-11-2024,,,60,OPD,
5486,22-11-2024,"ABLEKUMA
MAAME NKRAN",39 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD",,No,Insured,,,,,22-11-2024,22-11-2024,,,50,OPD,
5539,22-11-2024,GBAWE ZERO TOP HILL,38 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW, E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW",,No,Non-Insured,,,business woman,,22-11-2024,22-11-2024,,,50,OPD,
5673,21-11-2024,KANESHIE,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,21-11-2024,21-11-2024,,,0,OPD,
5702,21-11-2024,Malam,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ]",,,21-11-2024,21-11-2024,,,0,OPD,
5703,21-11-2024,ODORKOR OFFICIAL TOWN,85 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel | OD |  For 10 Days  ], SDILEGE ADVANCE(COLLAGEN+SODIUM HYAURONATE+GINKGO BILOBA+CARTILAGE+MSM+VITAMIN D3,B6,B12+OMEGA-3[  |  |  | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet | OD |  For 60 Days  ]","POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel ], SDILEGE ADVANCE(COLLAGEN+SODIUM HYAURONATE+GINKGO BILOBA+CARTILAGE+MSM+VITAMIN D3,B6,B12+OMEGA-3[  |  |  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], NIFEDIPINE 30MG SUSTAIN RELEASE[ NIFEMAX SR 30MG | 30MG | Tablet ]",AGED,,21-11-2024,21-11-2024,,,0,OPD,
5716,21-11-2024,sowutuom ,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | BDS |  For 60 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ]",,,21-11-2024,21-11-2024,,,0,OPD,
5717,21-11-2024,MALLAM-MASALACHI,75 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ],VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ],,,21-11-2024,21-11-2024,,,10,OPD,
5719,21-11-2024,nwe aplaku,76 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel | BDS |  For 10 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 60 Days  ]","POLAR ICE GEL[ POLAR ICE GEL | 500G | Gel ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-11-2024,21-11-2024,,,0,OPD,
5720,21-11-2024,awoshie,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ],LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ],,,21-11-2024,21-11-2024,,,0,OPD,
5724,21-11-2024,tetegu,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ]",,,21-11-2024,21-11-2024,,,0,OPD,
5730,21-11-2024,MALLAM JUNC,69 Year(s),Female,SPECIALIST CLINIC ,CONSULTATION REVIEW (ADULT),,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","M43.02 [Spondylolysis, cervical region]  ==> NEW",No,Insured,DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ],,,,21-11-2024,21-11-2024,,,170,OPD,
5736,21-11-2024,KASOA,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ]",TRADER,,21-11-2024,21-11-2024,,,0,OPD,
5783,21-11-2024,kasoa,67 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,APHRODISIA ROOT[ HERBAL | 70G | Package | Daily |  For 7 Days  ],APHRODISIA ROOT[ HERBAL | 70G | Package ],,,21-11-2024,21-11-2024,,,0,OPD,
5787,21-11-2024,BULEMI,77 Year(s),Male,SPECIALIST CLINIC ,CONSULTATION REVIEW (ADULT),,No Outcome,NA ,E08.22 [Diabetes mellitus due to underlying condition with diabetic chronic kidney disease]  ==> OLD,,No,Insured,IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | OD |  For 30 Days  ],IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ],,,21-11-2024,21-11-2024,,,170,OPD,
5797,21-11-2024,"AWOSHIE, A-LANG",61 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,Unemployed,,21-11-2024,21-11-2024,,,50,OPD,
5812,21-11-2024,OLD BARRIE,57 Year(s),Female,EYE CLINIC ,Review Consultation Adult ,,No Outcome,NA ,"E08.3293 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, bilateral]  ==> RECURRING",,No,Non-Insured,,,TRADER,,21-11-2024,21-11-2024,,,120,OPD,
5814,21-11-2024,ABLEKUMAN,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Once |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,,,21-11-2024,21-11-2024,,,0,OPD,
5818,21-11-2024,Mile 11,52 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,TRADER,,21-11-2024,21-11-2024,,,60,OPD,
5819,21-11-2024,"gbawe
bulemi",72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | BDS |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-11-2024,21-11-2024,,,10,OPD,
5821,21-11-2024,GBAWE,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 60 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ]","VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,21-11-2024,21-11-2024,,,0,OPD,
5865,21-11-2024,"GBAWE, TOIP BASE",38 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,"E78.5 [Hyperlipidaemia, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 20 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,21-11-2024,21-11-2024,,,10,OPD,
5900,21-11-2024,LAPAZ NEW MARKET,46 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Non-Insured,,,FOOD VENDOR,,21-11-2024,21-11-2024,,,30,OPD,
5920,21-11-2024,ACCRA-AKOTOLANTEY,64 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet ]",ELECTRICIAN,,21-11-2024,21-11-2024,,,0,OPD,
5990,21-11-2024,"MCCARTH HILL
8TH AVENUE",71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"SIDME PRO (ANTIOXIDANTS+LYCOPENE+ALPHA LIPOIC ACID+METHYLCOBALAMIN[ SIDME PRO |  | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 60 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 60 Days  ]","SIDME PRO (ANTIOXIDANTS+LYCOPENE+ALPHA LIPOIC ACID+METHYLCOBALAMIN[ SIDME PRO |  | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",Retired,,21-11-2024,21-11-2024,,,0,OPD,
6054,21-11-2024,"GBAWE
BULEMIN",48 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,,,21-11-2024,21-11-2024,,,50,OPD,
6078,21-11-2024,NEW BORTIANOR,64 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,business woman,,21-11-2024,21-11-2024,,,50,OPD,
6516,20-11-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,20-11-2024,20-11-2024,,,0,OPD,
6618,20-11-2024,SCC,54 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,B37.3 [Candidiasis of vulva and vagina]  ==> NEW,No,Non-Insured,"INSULIN SOLUBLE HM100UNITS/ML[  |  |  | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,,,20-11-2024,20-11-2024,,,120,OPD,
6646,20-11-2024,SANTA MARIA,70 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,"E10.40 [Type 1 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], TAURINE+ACETYLCYSTEINE (NEFROSAVE PLUS)[ NEFROSAVE PLUS  |  | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",TRADER,,20-11-2024,20-11-2024,,,5,OPD,
6648,20-11-2024,kasoa,80 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,20-11-2024,20-11-2024,,,0,OPD,
7359,20-11-2024,MALLAM,61 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> OLD,"I15.8 [Other secondary hypertension]  ==> OLD, A40.0 [Sepsis due to streptococcus, group A]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BID |  For 7 Days  ], POVIDONE+METRONIDAZOLE (DREZ) SOLUTION 30ML[ DREZ  | 30ML | Solution | Stat |  For 1 Days  ]",,,,20-11-2024,20-11-2024,,,0,OPD,
7372,20-11-2024,ADENTA-FAFRAHA,41 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.29 [Diabetes mellitus due to underlying condition with other diabetic kidney complication]  ==> NEW,"A40.0 [Sepsis due to streptococcus, group A]  ==> NEW, R52.0 [Acute pain]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], DICLOFENAC INJECTION 75MG[ DICLOFENAC | 75MG/3ML | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], DICLOFENAC INJECTION 75MG[ DICLOFENAC | 75MG/3ML | Injection ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",Self Employed,,20-11-2024,20-11-2024,,,0,OPD,
7489,19-11-2024,ANYAA,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,19-11-2024,19-11-2024,,,0,OPD,
7498,19-11-2024,GBAWE - ,51 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,,,TRADER,,19-11-2024,19-11-2024,,,50,OPD,
7499,19-11-2024,AWOSHIE,76 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,N34.2 [Other urethritis]  ==> NEW,No,Insured,"INSULIN SOLUBLE HM100UNITS/ML[  |  |  | PRN |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","INSULIN SOLUBLE HM100UNITS/ML[  |  |  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",pension,,19-11-2024,19-11-2024,,,0,OPD,
7518,19-11-2024,IRON CITY,69 Year(s),Female,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E11.36 [Type 2 diabetes mellitus with diabetic cataract]  ==> NEW,,No,Insured,,,,,19-11-2024,19-11-2024,,,15,OPD,
7541,19-11-2024,"ALIU MAHAMA ROAD
DANSOMAN ",74 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,19-11-2024,19-11-2024,,,0,OPD,
7549,19-11-2024,new weija azumah,65 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> OLD","E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD",No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 60 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]","PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,19-11-2024,19-11-2024,,,0,OPD,
7550,19-11-2024,BORTINAOR ,69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.01 [Diabetes mellitus due to underlying condition with hyperosmolarity with coma]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INDAPAMIDE SR [ Natrilix | 1.5MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], GLICLAZIDE [ DIAMICRON | 60MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 0 Days  ]","INDAPAMIDE SR [ Natrilix | 1.5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLICLAZIDE [ DIAMICRON | 60MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,19-11-2024,19-11-2024,,,0,OPD,
7559,19-11-2024,WEIJA POLICE STATION,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",driver,,19-11-2024,19-11-2024,,,0,OPD,
7612,19-11-2024,"KWASHIEMAN
ADE JUNCTION",62 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD",,No,Insured,,,,,19-11-2024,19-11-2024,,,60,OPD,
7663,19-11-2024,MCCARTHY HILL,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,19-11-2024,19-11-2024,,,0,OPD,
7711,19-11-2024,ABLEKUMAH-AGAPE,46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily AC |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 60 Days  ]","VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",TRADER,,19-11-2024,19-11-2024,,,0,OPD,
7712,19-11-2024,DANSOMAN,85 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, R73.9 [Hyperglycaemia, unspecified]  ==> OLD",,No,Non-Insured,,,,,19-11-2024,19-11-2024,,,50,OPD,
7734,19-11-2024,NEW WEIJA,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 60 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | OD |  For 60 Days  ], GLICLAZIDE [ DIAMICRON | 60MG | Tablet | OD |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ], LISINOPRIL TABLET 20MG[ LISINOPRIL | 20MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], GLICLAZIDE [ DIAMICRON | 60MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LISINOPRIL TABLET 20MG[ LISINOPRIL | 20MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,19-11-2024,19-11-2024,,,0,OPD,
7750,19-11-2024,SWOTUM,86 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], MELATONIN[ RESTWELL | 6MG | Tablet | OD |  For 6 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | OD |  For 5 Days  ]",,,,19-11-2024,19-11-2024,,,0,OPD,
7792,19-11-2024,"new bortianor ,broadcasting",74 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.622 [Diabetes mellitus due to underlying condition with other skin ulcer]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,19-11-2024,19-11-2024,,,0,OPD,
7797,19-11-2024,AMANFROM-GALILEA,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 30 Days  ],PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ],,,19-11-2024,19-11-2024,,,0,OPD,
7872,19-11-2024,TETEGU JUNCTION,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,,,19-11-2024,19-11-2024,,,0,OPD,
7895,19-11-2024,SANTA MARIA,70 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E10.40 [Type 1 diabetes mellitus with diabetic neuropathy, unspecified]  ==> NEW",I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 1 Days  ],,TRADER,,19-11-2024,19-11-2024,,,0,OPD,
7997,19-11-2024,KWASHIEMAN,70 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.649 [Diabetes mellitus due to underlying condition with hypoglycemia without coma]  ==> OLD,,No,Insured,,,,,19-11-2024,19-11-2024,,,0,OPD,
8026,19-11-2024,gbawe,84 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment | OD |  For 10 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BID |  For 90 Days  ]","POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,19-11-2024,19-11-2024,,,0,OPD,
8337,19-11-2024,AWOSHIE,76 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,pension,,19-11-2024,19-11-2024,,,145,OPD,
8368,18-11-2024,KASOA,48 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> OLD,,No,Insured,,,Para Professional,,18-11-2024,18-11-2024,,,110,OPD,
8376,18-11-2024,"NSUNFA, ABLEKUMA",50 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.01 [Type 2 diabetes mellitus with hyperosmolarity with coma]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 7 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",STEEL BENDER,,18-11-2024,18-11-2024,,,0,OPD,
8394,18-11-2024,scc red top,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,18-11-2024,18-11-2024,,,10,OPD,
8395,18-11-2024,anyaa nic,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,18-11-2024,18-11-2024,,,10,OPD,
8396,18-11-2024,bubueshie,55 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,18-11-2024,18-11-2024,,,10,OPD,
8397,18-11-2024,KASOA,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.42 [Diabetes mellitus due to underlying condition with diabetic polyneuropathy]  ==> OLD,,No,Insured,,,,,18-11-2024,18-11-2024,,,5,OPD,
8400,18-11-2024,mallam,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ]",,,,18-11-2024,18-11-2024,,,0,OPD,
8402,18-11-2024,"WEIJA
MANDELA",49 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,18-11-2024,18-11-2024,,,0,OPD,
8447,18-11-2024,MALLAM,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 60 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]",,,,18-11-2024,18-11-2024,,,10,OPD,
8452,18-11-2024,ABLEKUMA JOMA,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]",,TRADER,,18-11-2024,18-11-2024,,,10,OPD,
8461,18-11-2024,"GBAWE , CP ",62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | OD |  For 5 Days  ]",,TRADER,,18-11-2024,18-11-2024,,,10,OPD,
8512,18-11-2024,TETEGU,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ],LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ],,,18-11-2024,18-11-2024,,,10,OPD,44011/19
8514,18-11-2024,awoshie,86 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 60 Days  ], MULTIVITAMIN & MINERALS TABLET (ZINCOVIT)[ ZINCOVIT |  | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Nocte |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ]",,,,18-11-2024,18-11-2024,,,10,OPD,
8536,18-11-2024,malam,65 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,,,18-11-2024,18-11-2024,,,50,OPD,
8544,18-11-2024,TUBA JUNCTION,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 60 Days  ]",,pension,,18-11-2024,18-11-2024,,,50,OPD,
8591,18-11-2024,ABLEKUMA,69 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,Pensioner,,18-11-2024,18-11-2024,,,0,OPD,
8665,18-11-2024,BORTIANOR,44 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | TDS |  For 90 Days  ]",,,,18-11-2024,18-11-2024,,,0,OPD,
8718,18-11-2024,KANESHIE,51 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,TRADER,,18-11-2024,18-11-2024,,,20,OPD,
8784,18-11-2024,TOP BASE-GBAWE,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,PREGABALIN + MECOBALAMIN[ PREGATAS ME | 75MG|/750MCG | Tablet | OD |  For 30 Days  ],,business woman,,18-11-2024,18-11-2024,,,0,OPD,
8952,18-11-2024,WEIJA,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Nocte |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]",,,,18-11-2024,18-11-2024,,,0,OPD,
9414,17-11-2024,"OLD BARRIER, KASOA",63 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Nocte |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",PROPRIETOR,,17-11-2024,17-11-2024,,,105,OPD,
9464,17-11-2024,TUBA,37 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,,,STEEL BENDER,,17-11-2024,17-11-2024,,,0,OPD,
9507,17-11-2024,TUBA,37 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",STEEL BENDER,,17-11-2024,17-11-2024,,,80,OPD,
9519,17-11-2024,TETEGU,61 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"O2413 [Pre-existing type 2 diabetes mellitus, in the puerperium]  ==> NEW",,No,Non-Insured,SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ],SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ],driver,,17-11-2024,17-11-2024,,,70,OPD,
9574,17-11-2024,TETEGU,61 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,,,driver,,17-11-2024,17-11-2024,,,165,OPD,
9601,16-11-2024,MENDS KRROM,68 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,,No,Insured,,,,,16-11-2024,16-11-2024,,,10,OPD,
9632,16-11-2024,AGEGE ZONE SIX,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.622 [Type 2 diabetes mellitus with other skin ulcer]  ==> OLD,,No,Insured,,,Retired,,16-11-2024,16-11-2024,,,80,OPD,
9679,16-11-2024,"SANTA MARIA
DRUG STORE",71 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 15 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,16-11-2024,16-11-2024,,,10,OPD,
